Research studies seeking participants

Alpha-gal Syndrome Phenotyping Repository for Immunologic Specimens and Manifestations
Approved on:2026-11-10
Brief purpose of the study:This study aims to better understand the range of symptoms and immune findings in people with alpha-gal syndrome (AGS), identify distinct clinical subgroups, and develop tools for measuring disease severity for use in future clinical trials.
Brief summary of what participants will be asked to do:Eligible participants will complete an online questionnaire about their symptoms and health history and provide a blood sample and possibly a saliva sample at the MU Clinical Trials Support Unit (CTSU).
Basic eligibility criteria:Individuals are eligible if they have a confirmed diagnosis of alpha-gal syndrome (AGS), are suspected of having AGS, or if they are interested in participating in AGS-related research as control subjects.
Study contact for more information:alphagal@health.missouri.edu
IRB Number:2133646 MU
Return to list